ZInvestorHunting

Orrin Devinsky

Solo GP · New York, New York

US Angel

Named as one of two individuals (Manager of the General Partner of the Issuer) on the Form D for PhiFund2, LP, a $40M venture fund (Oct 2025). Also a non-executive director at 1 startup that filed Form D.

Investor IntelligenceVerified Activity

Angel Investment Confidence Score

Algorithmic score indicating recent deal velocity, check size reliability, and investment conviction in early-stage startups.

79/ 100
Selective Early-Stage AngelLatest deal Oct 2025
Deal VelocityLatest deal Oct 2025USA & Europe pipeline
Typical Check$400K–$1.2MPre-Seed / Seed
Primary FocusBiotech & PharmaPre-seed, Seed
Direct AccessWarm Intro Recommended1-click pitch match

Why Orrin Devinsky holds a 79/100 confidence score

  • Verified past startup investments on public record
  • Target check sizes calibrated between $400K–$1.2M
  • Clear domain thesis in Biotech & Pharma
  • Named as one of two individuals (Manager of the General Partner of the Issuer) on the Form D for PhiFund2, LP, a $40M venture fund (Oct 2025). Also a non-executive director at 1 startup that filed Form D.

Building in Biotech & Pharma? See how well your pitch deck matches Orrin Devinsky’s thesis.

Check My Startup Fit

Verified investment track record

Named as one of two individuals (Manager of the General Partner of the Issuer) on the Form D for PhiFund2, LP, a $40M venture fund (Oct 2025). Also a non-executive director at 1 startup that filed Form D.

Source: SEC Form D: PhiFund2, LP (Oct 14, 2025) · 1 more source

Stages
Pre-seed, Seed
Typical check (est.)
$400K–$1.2M
Verified deals
2 on file
Latest activity
Oct 2025
Pitch Readiness

Is Orrin Devinsky a fit for you?

See your AI startup fit score, verified contact channels, and warm paths through your network.

What sectors does Orrin Devinsky back?

Biotech & Pharma

Verified investments & deal activity

2 deals tracked

Recent startup investments, syndicate rounds, and public co-investments across the US and Europe.

  • PhiFund2, LP

    Invested through a fund

    Oct 2025
  • Somnum Pharma

    Board seat on the company's SEC filing · NY

    Nov 2024

Public Verification Sources

Data refreshed from SEC filings and public European announcements Oct 15, 2026. Is this you? Correct or remove this profile.

Syndicate IntelligenceUSA & Europe

Active Angels Similar to Orrin Devinsky

Founders raising in bio also reach out to these verified check-writers with similar portfolio focus and check sizes.

View all matching angels
Joseph Fernandes

Syndicate lead · Austin, TX

99/100
$145K–$595KActive Sep 2026
AI & MLBiotech & PharmaCybersecurity+1
Ben Horowitz

Solo GP · Menlo Park, CA

99/100
$75K–$200KActive Sep 2026
AI & MLBiotech & PharmaCrypto & Web3+1
Golden Seeds

Angel group · Scottsdale, AZ

97/100
$125K–$350KActive Oct 2026
HealthcareBiotech & PharmaConsumer+2
David Blivin

Solo GP · Santa Fe, NM

86/100
$800K–$2.4MActive Feb 2026
B2B SoftwareBiotech & PharmaClimate & Energy
Jeffrey Arnold

Solo GP · San Francisco, CA

88/100
Active Aug 2026
Biotech & Pharma
Paul Jun

Solo GP · San Francisco, CA

88/100
Active Aug 2026
Biotech & Pharma
AI Pitch & Angel Matcher

Raising pre-seed or seed for your startup?

Don’t pitch blindly. Our AI engine evaluates your startup against Orrin Devinsky and 100+ active US & European angels to deliver 3 perfect matches with tailored warm intros and pitch deck reviews.